- Home
- LNZA vs OSUR Comparison
LNZA vs OSUR Comparison
Compare LNZA & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNZA
- OSUR
- Stock Information
- Founded
- LNZA 2005
- OSUR 2000
- Country
- LNZA United States
- OSUR United States
- Employees
- LNZA N/A
- OSUR N/A
- Industry
- LNZA Major Chemicals
- OSUR Medical/Dental Instruments
- Sector
- LNZA Industrials
- OSUR Health Care
- Exchange
- LNZA Nasdaq
- OSUR Nasdaq
- Market Cap
- LNZA 199.8M
- OSUR 223.0M
- IPO Year
- LNZA N/A
- OSUR 1986
- Fundamental
- Price
- LNZA $0.20
- OSUR $2.99
- Analyst Decision
- LNZA Hold
- OSUR Hold
- Analyst Count
- LNZA 2
- OSUR 2
- Target Price
- LNZA $2.00
- OSUR $5.50
- AVG Volume (30 Days)
- LNZA 4.7M
- OSUR 624.9K
- Earning Date
- LNZA 04-15-2025
- OSUR 05-07-2025
- Dividend Yield
- LNZA N/A
- OSUR N/A
- EPS Growth
- LNZA N/A
- OSUR N/A
- EPS
- LNZA N/A
- OSUR N/A
- Revenue
- LNZA $49,592,000.00
- OSUR $185,827,000.00
- Revenue This Year
- LNZA $122.29
- OSUR N/A
- Revenue Next Year
- LNZA $21.36
- OSUR $7.55
- P/E Ratio
- LNZA N/A
- OSUR N/A
- Revenue Growth
- LNZA N/A
- OSUR N/A
- 52 Week Low
- LNZA $0.14
- OSUR $2.69
- 52 Week High
- LNZA $3.26
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- LNZA 37.18
- OSUR 43.10
- Support Level
- LNZA $0.15
- OSUR $2.84
- Resistance Level
- LNZA $0.31
- OSUR $3.10
- Average True Range (ATR)
- LNZA 0.04
- OSUR 0.15
- MACD
- LNZA 0.02
- OSUR 0.02
- Stochastic Oscillator
- LNZA 31.01
- OSUR 37.50
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. The company's goal is to reduce the need for virgin fossil fuels by challenging and striving to change the way the world uses carbon.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.